Overview

Montelukast for Early Life Wheezing

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Summary

This study will determine the effects of montelukast on the duration of wheezing in children 12 months to 3 years of age who visit a physician for care of a wheezing illness. Only patients from the Ankara area of Hacettepe University Medical Center in Turkey will be included in this study.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University of Massachusetts, Worcester

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Montelukast